PER 2.67% 7.3¢ percheron therapeutics limited

Chart, page-3846

  1. 3,098 Posts.
    lightbulb Created with Sketch. 500
    What do u think our X earnings ratio would be come commercialisation? 10, 20, 30, 40? If we have some big indication potentials x 40 wouldnt be excessive. I doubt our drug will stop at dmd. Later this year those animal tests will give insight to how high up the earnings ratio we'll fly.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.